This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of biologically active molecules. Its structure, featuring a trifluoromethyl group and a benzyl moiety, makes it a valuable building block for developing potential drug candidates, particularly in the design of enzyme inhibitors or receptor modulators. The trifluoromethyl group enhances the compound's metabolic stability and binding affinity, which is crucial in drug discovery. Researchers often employ it in the creation of compounds targeting neurological disorders, inflammation, or infectious diseases due to its ability to interact with specific biological targets. Additionally, its pyrrolidine core is advantageous for constructing molecules with improved pharmacokinetic properties.